§ Claim under review · Health
"A bizarre medical case showed that Diet Coke can have a very unusual use in medicine. A woman taking a GLP-1 medication developed a gastric bezoar, a hardened mass of undigested food in the stomach. Doctors treated her with 1.5 litres of Diet Coke over two days, and follow-up examination showed that the mass had dissolved." (Intake summary rendered it as "1.5 liters of Diet Coke a day, with the mass gone within two days." Post images read: BEFORE / AFTER 2 DAYS.)
Verdict
Mostly accurate
Confidence
MediumSummary
This one is largely accurate. A real medical case, reported by Live Science and NewsNation in July 2026, describes a 36-year-old Massachusetts woman on a GLP-1 weight loss drug who developed a gastric bezoar, a hardened mass of undigested food. She drank roughly 1.5 liters of Diet Coke, and a follow-up endoscopy found the mass had dissolved. Using cola to dissolve these masses is a recognized medical technique, supported by a published systematic review that found it fully dissolves such masses in about half of cases. Two details in the viral version are off: the cola was a single scaled-down dose, not 1.5 liters a day, and doctors also stopped her GLP-1 medication and gave her another prescription, so soda was not the only treatment. This is also a single patient case, and the doctors themselves wrote that they do not understand why cola works. The before-and-after images in the post could not be verified as coming from this case, and the original journal publication was not directly located.
The readings
key figures from the evidenceDiet Coke volume given to patient in the case report
phytobezoar resolution success rate with Coca-Cola in systematic review
standard cola dose protocol for bezoar dissolution within 12 hours
Why this verdict
Evidence
The underlying case is real and was covered by both Live Science and NewsNation. NewsNation reported that a soda played an unexpected role in treating a rare abdominal blockage in a Massachusetts woman, a 36-year-old patient who went to the emergency room after about a month of nausea, vomiting and decreased appetite.
She drank about 1.5 liters of Diet Coke, roughly half the amount typically recommended for treating a bezoar, because she did not like the carbonation; the next day she reported a "tugging" sensation in her abdomen followed by relief from nausea and discomfort, and a follow-up endoscopy showed the bezoar had dissolved.
The same outlet reported the mass was not blocking the opening to her small intestine but was taking up significant space and making it harder for food to move through her digestive system, and that physicians believe the bezoar formed due to delayed gastric emptying, a known effect of GLP-1 medications such as semaglutide.
The treating clinicians' own framing was cautious. Live Science quoted the case report as stating that "Existing evidence, largely from case series and anecdotal experiences, supports the administration of 3 liters [0.8 gallons] of cola, either orally or through a nasogastric tube, within a 12-hour window."
The report also stated that "It is not well understood whether acidity, carbonation, or another mechanism accounts for dissolution of the bezoar."
The general technique is established in the literature, not a novelty. A systematic review found that in 91.3% of cases phytobezoar resolution with Coca-Cola administration was successful, either as a single treatment (50%) or combined with further endoscopic techniques, with only 4 patients requiring surgery.
Its authors concluded that Coca-Cola completely dissolves gastric phytobezoars in about half of cases and facilitates complete dissolution by subsequent endoscopic techniques in the majority of patients.
The GLP-1 to bezoar link also has independent support. A 2025 Cureus case report described acute small bowel obstruction due to a bezoar in a 65-year-old woman on semaglutide for weight loss, with the authors postulating that semaglutide-induced gastroparesis and slow intestinal transit may have contributed to bezoar formation.
Findings
✓ What's accurate 7
- A real, media-documented clinical case exists, published as a case report and covered by Live Science and NewsNation in July 2026.
- The patient was taking a GLP-1 receptor agonist and developed a gastric bezoar.
- Diet Coke was the dissolution agent used, in an approximate volume of 1.5 liters.
- A follow-up endoscopy found the bezoar had dissolved.
- The approximate two-day timeframe is consistent with reporting: symptom relief the day after ingestion, with dissolution confirmed on follow-up endoscopy.
- The post's closing qualifier, that cola has been used in medically supervised bezoar treatments, is accurate and supported by a published systematic review.
- The MLA citation points to a real NewsNation article, though the date is off by about one day from the publication date indexed.
≈ What's misleading 6
- Dose and duration framing (omitted qualifier): the intake wording "1.5 liters a day" and the post's "over two days" both misdescribe the regimen. Reporting indicates a single scaled-down administration of about 1.5 liters, which was roughly half the standard 3-liters-in-12-hours protocol. This detail matters because it is the opposite of a daily maintenance regimen.
- Treatment was not cola alone (omitted qualifier): secondary coverage indicates doctors also took the patient off the GLP-1 medication and gave her a prescription. Presenting Diet Coke as the sole curative intervention overstates its isolated role.
- Single case presented as a general property (temporal and scope overreach): "Diet Coke can have a very unusual use in medicine" is loose but defensible given the systematic review; however, the before/after visual format implies reproducible, predictable efficacy that a single case cannot demonstrate. Even the systematic review found complete dissolution with cola alone in only about half of cases.
- Mechanism implied but unknown: the framing suggests Diet Coke reliably "dissolves" masses, while the treating clinicians stated the mechanism is not understood.
- Causal attribution to the GLP-1 drug is a clinical inference, not an established cause. Headlines used "likely caused" and the post drops that hedge.
- Brand framing: the on-image text "Diet Coke - NO SUGAR NO CALORIES" reads as product marketing attached to a medical case. Diet cola was chosen here because the patient had diabetes, not because sugar-free formulations are therapeutically superior.
? What's uncertain 6
- The original published case report (journal, authors, DOI, exact wording of the imaging and endoscopy findings) was not retrieved. Search quota was exhausted after the sources listed above.
- Whether the "BEFORE" and "AFTER 2 DAYS" images in the post are the actual endoscopic or imaging images from this case, or unrelated stock or borrowed images. This could not be verified.
- The exact interval between cola administration and the confirmatory follow-up endoscopy.
- The bezoar's composition, its precise measured size, and whether any residual material remained.
- What additional prescription the patient received and what role it played.
- Whether the MLA date of 22 July 2026 reflects an update, a syndication, or a transcription error.
Sources
6 of 7 linked to recordsLadas et al., "Systematic review: Coca-Cola can effectively dissolve gastric phytobezoars as a first-line treatment," Alimentary Pharmacology & Therapeutics (2013)
Live Science, "Diagnostic dilemma: Huge mass in woman's stomach was likely caused by Ozempic-style drug and dissolved with diet soda," July 2026
NewsNation, "Doctors use Diet Coke to dissolve woman's rare stomach mass likely caused by of GLP-1 drug," 21 July 2026
Keng et al., "A Case Report of Bezoar-Induced Small Bowel Obstruction: A Potential Surgical Complication of Semaglutide," Cureus, Dec 2025
Coca-Cola dissolution therapy for duodenal bezoar, case report, PubMed 2026
Dexerto, July 2026
NOT FOUND: the original published case report (journal, authors, DOI). Search quota exhausted before it could be located.